相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Keratin 19: a key role player in the invasion of human hepatocellular carcinomas
Olivier Govaere et al.
GUT (2014)
Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinoma
Bhavna Rani et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Patient-Derived Tumor Xenografts: Transforming Clinical Samples into Mouse Models
Despina Siolas et al.
CANCER RESEARCH (2013)
A Phase II and Biomarker Study of Ramucirumab, a Human Monoclonal Antibody Targeting the VEGF Receptor-2, as First-Line Monotherapy in Patients with Advanced Hepatocellular Cancer
Andrew X. Zhu et al.
CLINICAL CANCER RESEARCH (2013)
A Hepatocellular Carcinoma 5-Gene Score Associated With Survival of Patients After Liver Resection
Jean-Charles Nault et al.
GASTROENTEROLOGY (2013)
Molecular Profiling of Stroma Identifies Osteopontin as an Independent Predictor of Poor Prognosis in Intrahepatic Cholangiocarcinoma
Laurent Sulpice et al.
HEPATOLOGY (2013)
Transforming Growth Factor-β (TGF-β)-mediated Connective Tissue Growth Factor (CTGF) Expression in Hepatic Stellate Cells Requires Stat3 Signaling Activation
Yan Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
Philip J. Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study
Josep M. Llovet et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study
Armando Santoro et al.
LANCET ONCOLOGY (2013)
Targeting the NF-κB Pathway in Cancer Therapy
Derek J. Erstad et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2013)
The roles of TGFβ in the tumour microenvironment
Michael Pickup et al.
NATURE REVIEWS CANCER (2013)
Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma
Josep M. Llovet et al.
CLINICAL CANCER RESEARCH (2012)
Phase II, Open-Label Study of Brivanib as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma
Richard S. Finn et al.
CLINICAL CANCER RESEARCH (2012)
PI3K class IB controls the cell cycle checkpoint promoting cell proliferation in hepatocellular carcinoma
Francesco Dituri et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma
Wolfgang Sieghart et al.
JOURNAL OF HEPATOLOGY (2012)
Patient-derived tumour xenografts as models for oncology drug development
John J. Tentler et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Kinase activation profile associated with TGF-β-dependent migration of HCC cells: a preclinical study
Emilia Fransvea et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Hepatic stellate cells stimulate HCC cell migration via laminin-5 production
Angela Santamato et al.
CLINICAL SCIENCE (2011)
MicroRNA-Based Classification of Hepatocellular Carcinoma and Oncogenic Role of miR-517a
Sara Toffanin et al.
GASTROENTEROLOGY (2011)
Field-Practice Study of Sorafenib Therapy for Hepatocellular Carcinoma: A Prospective Multicenter Study in Italy
Massimo Iavarone et al.
HEPATOLOGY (2011)
Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic review
Ketao Jin et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2010)
Sorafenib Overcomes TRAIL Resistance of Hepatocellular Carcinoma Cells through the Inhibition of STAT3
Kuen-Feng Chen et al.
CLINICAL CANCER RESEARCH (2010)
Cancer Statistics, 2009
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Expression of Autotaxin and Lysophosphatidic Acid Receptors Increases Mammary Tumorigenesis, Invasion, and Metastases
Shuying Liu et al.
CANCER CELL (2009)
Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinoma
Yujin Hoshida et al.
CANCER RESEARCH (2009)
Direct In Vivo Xenograft Tumor Model for Predicting Chemotherapeutic Drug Response in Cancer Patients
B. Rubio-Viqueira et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study
Mei-Hwei Chang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Dysregulation of apoptosis in hepatocellular carcinoma cells
Isabel Fabregat
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
TRAIL-induced apoptosis of hepatocellular carcinoma cells is augmented by targeted therapies
Bruno Christian Koehler et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors
Shuji Sumie et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Focal gains of VEGFA and molecular classification of hepatocellular carcinoma
Derek Y. Chiang et al.
CANCER RESEARCH (2008)
Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004
Cristina Bosetti et al.
HEPATOLOGY (2008)
Transforming growth factor-β gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer
Cedric Coulouarn et al.
HEPATOLOGY (2008)
Connective tissue growth factor (CTGF) and cancer progression
Chia-Yu Chu et al.
JOURNAL OF BIOMEDICAL SCIENCE (2008)
Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases
Olav A. Gressner et al.
LIVER INTERNATIONAL (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
Yujin Hoshida et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Etiology-dependent molecular mechanisms in human hepatocarcinogenesis
Christof Schlaeger et al.
HEPATOLOGY (2008)
Laminin-5 stimulates hepatocellular carcinoma growth through a different function of α6β4 and α3β1 integrins
Carlo Bergamini et al.
HEPATOLOGY (2007)
Epidemiology of hepatocellular carcinoma in USA
Hashem B. El-Serag
HEPATOLOGY RESEARCH (2007)
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets
Sandrine Boyault et al.
HEPATOLOGY (2007)
Establishment of human tumor xenografts in immunodeficient mice
Christopher L. Morton et al.
NATURE PROTOCOLS (2007)
Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5
Li Liu et al.
CANCER RESEARCH (2006)
Phase II study of sorafenib in patients with advanced hepatocellular carcinoma
Ghassan K. Abou-Alfa et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Laminin-5 with transforming growth factor-β1 induces epithelial to mesenchymal transition in hepatocellular carcinoma
G Giannelli et al.
GASTROENTEROLOGY (2005)
Mutated PI 3-kinases - Cancer targets on a silver platter
S Kang et al.
CELL CYCLE (2005)
Predictive value of biological markers for hepatocellular carcinoma patients treated with orthotopic liver transplantation
M Fiorentino et al.
CLINICAL CANCER RESEARCH (2004)
Molecular profiling of human hepatocellular carcinoma defines mutually exclusive interferon regulation and insulin-like growth factor II overexpression
K Breuhahn et al.
CANCER RESEARCH (2004)
Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern Cooperative Oncology Group Trial E2196
JA Sparano et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Angiogenesis and hepatocellular carcinoma
D Semela et al.
JOURNAL OF HEPATOLOGY (2004)
Oncogenic mutations of PIK3CA in human cancers
Y Samuels et al.
CELL CYCLE (2004)
Gross appearance of hepatocellular carcinoma reflects E-cadherin expression and risk of early recurrence after surgical treatment
J Inayoshi et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2003)
Binding to EGF receptor of a laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution
S Schenk et al.
JOURNAL OF CELL BIOLOGY (2003)
Occurrence of portal vein tumor thrombus in hepatocellular carcinoma affects prognosis and survival. A retrospective clinical study of 150 cases
G Giannelli et al.
HEPATOLOGY RESEARCH (2002)
Epithelial-mesenchymal transitions in tumour progression
JP Thiery
NATURE REVIEWS CANCER (2002)
The snail superfamily of zinc-finger transcription factors
MA Nieto
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Role of the alpha 3 beta 1 and alpha 6 beta 4 integrins in tumor invasion
G Giannelli et al.
CLINICAL & EXPERIMENTAL METASTASIS (2002)
The microenvironment of the tumour-host interface
LA Liotta et al.
NATURE (2001)
Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis
S Jonas et al.
HEPATOLOGY (2001)
Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: A prospective study
RTP Poon et al.
ANNALS OF SURGERY (2001)
Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5
N Koshikawa et al.
JOURNAL OF CELL BIOLOGY (2000)
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in bronchial squamous preinvasive lesions
FB Galateau-Salle et al.
HUMAN PATHOLOGY (2000)
分享论文
